Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis

C. M. Sloan; L. J. Sherrard; G. G. Einarsson; M. M. Tunney; D. G. Downey

doi:10.1016/S1569-1993(21)01175-9

Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	P149
Pages (from-to)	S84-S85
Journal	Journal of Cystic Fibrosis
Volume	20
Issue number	Supplement 1
DOIs	https://doi.org/10.1016/S1569-1993(21)01175-9
Publication status	Published - 01 Jun 2021
Event	44th European Cystic Fibrosis Conference 2021 - virtual, online Duration: 09 Jun 2021 → 12 Jun 2021 https://www.ecfs.eu/digital2021

Access to Document

10.1016/S1569-1993(21)01175-9Licence: Unspecified

Levofloxacin: reducing the risk of Pseudomonas aeruginosa resistance
Sloan, C. M. (Author), Downey, D. (Supervisor) & Sherrard, L. (Supervisor), Dec 2024
Student thesis: Doctoral Thesis › Doctor of Philosophy

Cite this

@article{bc00e7f6a7ed41d4b242444cfdfa64b6,

title = "Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis",

author = "Sloan, \{C. M.\} and Sherrard, \{L. J.\} and Einarsson, \{G. G.\} and Tunney, \{M. M.\} and Downey, \{D. G.\}",

year = "2021",

month = jun,

day = "1",

doi = "10.1016/S1569-1993(21)01175-9",

language = "English",

volume = "20",

pages = "S84--S85",

journal = "Journal of Cystic Fibrosis",

issn = "1569-1993",

publisher = "Elsevier B.V.",

number = "Supplement 1",

note = "44th European Cystic Fibrosis Conference 2021 ; Conference date: 09-06-2021 Through 12-06-2021",

url = "https://www.ecfs.eu/digital2021",

}

TY - JOUR

T1 - Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis

AU - Sloan, C. M.

AU - Sherrard, L. J.

AU - Einarsson, G. G.

AU - Tunney, M. M.

AU - Downey, D. G.

PY - 2021/6/1

Y1 - 2021/6/1

U2 - 10.1016/S1569-1993(21)01175-9

DO - 10.1016/S1569-1993(21)01175-9

M3 - Meeting abstract

SN - 1569-1993

VL - 20

SP - S84-S85

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

IS - Supplement 1

M1 - P149

T2 - 44th European Cystic Fibrosis Conference 2021

Y2 - 9 June 2021 through 12 June 2021

ER -

Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis

Access to Document

Student theses

Levofloxacin: reducing the risk of Pseudomonas aeruginosa resistance

Cite this